Showing results (1181-1190 of 3,397) with videos related to
Sort By:
Pageof 340
Neuromuscular Disorders : NMD|January 1, 1991
Different gene loci for hyperkalemic and hypokalemic periodic paralysisB Fontaine, J Trofatter, G A Rouleau, et al.Neuromuscular Disorders : NMD|January 1, 1991
Late onset lipid storage myopathy due to multiple acyl CoA dehydrogenase deficiency triggered by valproateA Papadimitriou, S ServideiNeuromuscular Disorders : NMD|January 1, 1991
X-linked and FSH dystrophies in one familyB R Lecky, J M MacKenzie, A P Read, et al.Neuromuscular Disorders : NMD|January 1, 1991
Mapping of dystrophin brain promoter: a deletion of this region is compatible with normal intellectJ T den Dunnen, L Casula, A Makover, et al.Neuromuscular Disorders : NMD|January 1, 1991
Allografts of muscle precursor cells persist in the non-tolerized hostD J Watt, J E Morgan, T A PartridgeNeuromuscular Disorders : NMD|January 1, 1991
Why is the gracilis muscle relatively uninvolved in neuromuscular disorders?M S Schwartz, M Swash, J RyanNeuromuscular Disorders : NMD|January 1, 1991
Procainamide therapy, physical performance and energy expenditure in the Schwartz-Jampel syndromeF Spaans, A Wagenmakers, W Saris, et al.Neuromuscular Disorders : NMD|March 25, 2014
GNE myopathy: a prospective natural history study of disease progressionMadoka Mori-Yoshimura, Yasushi Oya, Hiroyuki Yajima, et al.Neuromuscular Disorders : NMD|March 25, 2014
Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophyChitra C Iyer, Vicki L McGovern, Dawnne O Wise, et al.Neuromuscular Disorders : NMD|March 18, 2008
Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiencyDilair Baban, Kay E DaviesPageof 340